Enveric Biosciences Inc (NASDAQ: ENVB) — Healthcare · Share Price, Chart & Market Data
About: Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. The company offers product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. It also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. The company was founded in 2020 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $5.04 (+25.37%)
ENVBEnveric Biosciences Inc
Loading watchlist status…
Trade ENVB now
Enveric Biosciences Inc share price
ENVB price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 10:47 am GMT+0
ENVB price performance
49.555%
5D
168.085%
1M
37.33%
YTD
-68.889%
1Y
ENVB price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 10:47 am GMT+0
ENVB details
ENVB Market Signals